Sign In
Buy AGIO
$27.68
+1.17 (+4.41%)
At Close: Jun 03, 2026
Agios Pharmaceuticals Q1 2020 Earnings Preview
09:30pm, Wednesday, 29'th Apr 2020
Agios Pharmaceuticals (NASDAQ:AGIO) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is -$1.64 (-3.1% Y/Y) and the consensus Revenue
Agios Pharmaceuticals (AGIO) Set to Announce Earnings on Thursday
10:12am, Tuesday, 28'th Apr 2020
Agios Pharmaceuticals (NASDAQ:AGIO) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, April 30th. Analysts expect Agios Pharmaceuticals to post earnings of
The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight
08:37pm, Sunday, 26'th Apr 2020
The week ended April 24 turned out to be an up-and-down one for biotech stocks, as the sector swayed along with the broader market. Two FDA approvals came through this week,...
Have Insiders Been Buying Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares?
12:36pm, Sunday, 26'th Apr 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Agios Pharmaceuticals Inc (NASDAQ:AGIO) Expected to Announce Quarterly Sales of $30.86 Million
07:30am, Friday, 24'th Apr 2020
Brokerages expect Agios Pharmaceuticals Inc (NASDAQ:AGIO) to post sales of $30.86 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Agios
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
04:32pm, Thursday, 23'rd Apr 2020
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
04:32pm, Thursday, 23'rd Apr 2020
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stocks To Watch: Agios Pharmaceuticals Sees Relative Strength Rating Rise To 82
12:00am, Tuesday, 21'st Apr 2020Agios Pharmaceuticals (NASDAQ:AGIO) Upgraded to Buy by BidaskClub
07:38am, Saturday, 18'th Apr 2020
Agios Pharmaceuticals (NASDAQ:AGIO) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Satu
Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020
11:00am, Thursday, 16'th Apr 2020
CAMBRIDGE, Mass., April 16, 2020 -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today.
Here's Why We're Not Too Worried About Agios Pharmaceuticals's (NASDAQ:AGIO) Cash Burn Situation
10:03am, Thursday, 16'th Apr 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Agios to Webcast Conference Call of First Quarter —…—… Financial Results on April ...
12:00am, Thursday, 16'th Apr 2020Time to Pull the Trigger? RBC Offers 2 Stocks to Buy
01:01pm, Wednesday, 15'th Apr 2020
For the first time ever, investment firm RBC Capital released its Small-Cap Growth Idea list, made up of stocks with market caps below $5 billion at the time of publishing, and average daily trading v
Time to Pull the Trigger? RBC Offers 2 Stocks to Buy
12:56pm, Wednesday, 15'th Apr 2020
For the first time ever, investment firm RBC Capital released its Small-Cap Growth Idea list, made up of stocks with market caps below $5 billion at the
Agios Pharmaceuticals Shows Improved Relative Strength; Still Shy Of Benchmark
08:57pm, Tuesday, 14'th Apr 2020
Agios Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
